Multifunctional Systems for Combined Delivery, Biosensing and Diagnostics

Dr. Grumezescu is Assistant Professor at the Department of Science and Engineering of Oxide Materials and Nanomaterials, in the Faculty of Applied Chemistry and Materials Science, with a second affiliation to the Faculty of Medical Engineering, at the Politehnica University of Bucharest in Romania. He is an experienced and oft-published researcher and editor in the field of nano and biomaterials, and he is the Editor-in-Chief of three journals: Biointerface Research in Applied Chemistry, Letters and Applied NanoBioScience, and Biomaterials and Tissue Engineering Bulletin. He also serves as editor or guest editor for several notable journals. Dr. Grumezescu has published 150 peer-reviewed papers, 20 book chapters, 6 co-authored books and 11 edited books.

1. Selective Effects of Azelaic Acid in Nanovesicles on Cell Lines2. Photodynamic Antimicrobial Action Based on Nanostructured Photosensitizers3. Conspectus on Nanotechnology in the Diagnosis and Management of Oral Cancer4. Lipid-Based Nanocarriers in Cancer Therapy5. Effect of Polymer-Based Nanoparticles on the Assay of Antimicrobial Drug Delivery Systems6. Nanometric Biopolymer Devices for Oral Delivery of Macromolecules of Clinical Significance7. The Use of Nanotechnology in Modern Pharmacotherapy8. Nanoparticles for Anti-Cancer Drug Delivery "Targeting to Overcome Multiple Drug Resistance"9. Application Potential of Engineered Liposomes in Tumor Targeting10. Plant Based Peroral Vaccines11. Platelet Rich Plasma Incorporated Nanostructures for Tissue Engineering Applications12. Targeted Nanotherapeutics Based on Cancer Biomarkers13. Therapeutic Nanoparticles for Targeted Delivery of Anticancer Drugs: State-Of-The-Art and Future Trends14. Pulmonary Administration of Biodegradable Drug Nanocarriers for More Efficacious Treatment of Fungal Infections in Lungs: Insights Based On Recent Findings15. Alternative Technologies to Improve Solubility of Ineffectively Water-Soluble Drugs16. Nanostructures For Tuberculosis Disease Treatment17. Recombinant Lactic Acid Bacteria Secreting OxdC as a Novel Therapeutic Tool for the Prevention of Kidney Stone Disease